Critical Care

official impact factor 4.60
Search for
Advanced search
Critical Care
Tools
Open Access Highly Access Email this article to a friend

Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy

Luigi Camporota, Eleonora Corno, Eleonora Menaldo, John Smith, Katie Lei, Richard Beale and Duncan Wyncoll*

Critical Care 2008, 12:R163 doi:10.1186/cc7163

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.